Skip to main content

Advertisement

Table 3 Multivariate analysis of risk factors for CNS relapse in the entire cohort

From: New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study

Variable HR 95% CI P
Bone involvement 4.21 1.38–12.77 0.011
Kidney involvement 3.85 1.05–14.19 0.043
ALP > 110U/L 3.59 1.25–10.34 0.018
ALB < 35g/L 3.63 1.25–10.51 0.018
Rituximab treatment 0.34 0.12–0.96 0.042
TTC ≤ 108 days 0.22 0.06–0.78 0.019
  1. HR hazard ratio, CI confidence interval. Other abbreviations as in Table 1